Actively Recruiting
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
Led by Institut de Cancérologie de Lorraine · Updated on 2025-12-22
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of two written information brochures, "Mon Parcours de Vie" volumes 2 and 3, on women with localized breast cancer. These brochures, developed by the French association "MON PARCOURS DE VIE" and provided by caregivers, aim to offer clear, supportive, and gentle guidance about the disease and treatment. The study focuses on how these documents affect anxiety and understanding during the initial announcement and management of localized breast cancer. Participants will receive the written brochures as part of their care. The study is observational and aims to assess the acceptability of the information, changes in anxiety levels, and patients' comprehension and satisfaction. The evaluation occurs within 14 days after exposure to the documents, with no experimental treatments or interventions involved. During the study, participants will be monitored for their reactions to the brochures, including anxiety scores and understanding levels. Researchers will measure acceptability, perception, comprehension, and satisfaction related to the information provided. The total study participation involves assessments within a two-week period following the provision of the brochures.
CONDITIONS
Brief Title
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with localized breast cancer consulting for medical treatment (chemotherapy+/- immunotherapy+/anti-HER2 targeted therapy)
- Diagnosis of invasive breast cancer for which there is an indication for local and medical treatment
- WHO 1
- Patient has understood, signed and dated the consent form
- Patient affiliated to the social security system
You will not qualify if you...
- Patient with metastatic breast cancer
- History of other cancer
- Patient unable to read or speak French
- Persons deprived of liberty or under guardianship (including curatorship).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 days
Participants with localized breast cancer consulting for medical treatment are observed to assess their acceptability and understanding of written information documents about their disease and treatments.
1 to 2 visits depending on assessments
Trial Site Locations
Total: 1 location
1
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, 54519
Actively Recruiting
Research Team
J
Jean-Louis MERLIN
D
Denise BECHET
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here